Study with Reslizumab in Patients With Severe Eosinophilic Asthma

- Eosinophils, Asthma
- Terminated

Study Title: A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma

Teva Identifier: C38072-AS-30066 | 2016-004661-23

ClinicalTrials.gov Identifier: NCT03052725

Study Status: Terminated

Trial Condition(s): Eosinophils, Asthma

Interventions: Drug: reslizumab

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: March 10, 2017 - February 22, 2018

Phase: Phase 3

Study Type

Interventional